Diabetic patients with painful peripheral neuropathy have higher levels of inflammatory markers than subjects without pain, and the elevation of interleukin (IL)-1, IL-6, and tumor necrosis factor α (TNF-α) are correlated with the progression of degenerative changes in the peripheral nerves. This evidence concerns the gene TNF and Pain.